Study suggests common cancer treatment does not work well for hospitalized patients

by

Immune checkpoint inhibitors (ICIs), a major type of cancer immunotherapy, don’t do much for hospitalized cancer patients, researchers at the Icahn School of Medicine at Mount Sinai report.

Leave A Comment

Your email address will not be published. Required fields are marked *